Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Net Cash Flow: 2020-2024

Historic Net Cash Flow for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to -$7.1 million.

  • Journey Medical's Net Cash Flow rose 420.81% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.5 million, marking a year-over-year increase of 864.29%. This contributed to the annual value of -$7.1 million for FY2024, which is 56.31% down from last year.
  • Per Journey Medical's latest filing, its Net Cash Flow stood at -$7.1 million for FY2024, which was down 56.31% from -$4.6 million recorded in FY2023.
  • Over the past 5 years, Journey Medical's Net Cash Flow peaked at $40.8 million during FY2021, and registered a low of -$17.1 million during FY2022.
  • For the 3-year period, Journey Medical's Net Cash Flow averaged around -$9.6 million, with its median value being -$7.1 million (2024).
  • Per our database at Business Quant, Journey Medical's Net Cash Flow skyrocketed by 1,085.34% in 2021 and then crashed by 141.82% in 2022.
  • Journey Medical's Net Cash Flow (MRY) stood at $3.4 million in 2020, then skyrocketed by 1,085.34% to $40.8 million in 2021, then tumbled by 141.82% to -$17.1 million in 2022, then surged by 73.28% to -$4.6 million in 2023, then plummeted by 56.31% to -$7.1 million in 2024.
  • Its Net Cash Flow stands at -$7.1 million for FY2024, versus -$4.6 million for FY2023 and -$17.1 million for FY2022.